Heroin Addiction and Related Clinical Problems最新文献

英文中文

Oximetry and acid-base balance features in pregnant women with pneumonia caused by SARS-COV-2 SARS-COV-2型肺炎孕妇血氧和酸碱平衡特征

IF 0.9 4区医学 Q3 Medicine

Heroin Addiction and Related Clinical Problems

Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa444

I. Andrievskaya, I. V. Zhukovets, V. S. Bardov, N. A. Ishutina, I. Dovzhikova, A. S. Abuldinov, Karen S. Lyazgian, V. Kolosov

引用次数: 0

Late Breaking Abstract - Acute multi-organ symptoms predict long COVID 急性多器官症状预示着长期的COVID

IF 0.9 4区医学 Q3 Medicine

Heroin Addiction and Related Clinical Problems

Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa453

S. Sahanic, P. Tymoszuk, D. Ausserhofer, Verena Rass, A. Pizzini, Götz Nordmeyer, K. Hüfner, K. Kurz, Paulina Maria Weber, T. Sonnweber, Anna Boehm, Magdalena Aichner, K. Cima, B. Böckle, C. Gollmann-Tepeköylü, J. Holfeld, S. Kiechl, A. Huber, C. Wiedermann, B. Sperner-Unterweger, R. Bellmann-Weiler, Herbert Bachler, G. Piccoliori, R. Helbok, G. Weiss, J. Löffler-Ragg

引用次数: 0

Impact of the COVID -19 pandemic on pleural infections: A multicentre retrospective analysis COVID -19大流行对胸膜感染的影响:一项多中心回顾性分析

IF 0.9 4区医学 Q3 Medicine

Heroin Addiction and Related Clinical Problems

Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa288

K. Ur Rehman, Eihab O Bedawi, P. Sivakumar, K. Ferguson, Syed Ajmal, Emma Graham, R. Panchal, J. Corcoran, Kevin G Blyth, N. Rahman, A. West

引用次数: 1

Can we treat Exercise Induced Laryngeal Obstruction with inhaled ipratropiumbromide? 吸入异丙托溴铵是否可以治疗运动性喉部梗阻?

IF 0.9 4区医学 Q3 Medicine

Heroin Addiction and Related Clinical Problems

Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa3307

P. Muralitharan, P. Carlsen, M. Vollsæter, M. Engan, I. Hammer, T. Halvorsen, O. Røksund, H. Clemm

引用次数: 0

Defining health states with visual analogue scale and Leicester Cough Questionnaire in chronic cough 用视觉模拟量表和莱斯特咳嗽问卷确定慢性咳嗽患者的健康状态

IF 0.9 4区医学 Q3 Medicine

Heroin Addiction and Related Clinical Problems

Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa3144

P. S. Cho, K. Rhatigan, H. Fletcher, C. Jolley, R. Turner, S. Birring, P. S. Cho

引用次数: 1

Late Breaking Abstract - Post-trial follow-up after a randomized clinical trial of COVID-19 convalescent plasma 摘要- COVID-19恢复期血浆随机临床试验后随访

IF 0.9 4区医学 Q3 Medicine

Heroin Addiction and Related Clinical Problems

Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.oa4197

María Teresa Panighetti, I. Esteban, F. Polack

引用次数: 0

Late Breaking Abstract - Development of a multivariate model for clinical prediction in COVID 19 infected patients 摘要-建立新冠肺炎患者临床预测的多变量模型

IF 0.9 4区医学 Q3 Medicine

Heroin Addiction and Related Clinical Problems

Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa3894

A. Camelier, A. Meireles, A. Oliveira, Victor Costa Araujo, Marcos Filipe Lima Santos, L. Correia

引用次数: 0

Outcomes for patients receiving telemedicine-delivered medication-based treatment for Opioid Use Disorder: A retrospective chart review. 接受远程医疗药物治疗的阿片类药物使用障碍患者的疗效：回顾性病历

IF 0.8 4区医学 Q4 SUBSTANCE ABUSE

Heroin Addiction and Related Clinical Problems

Pub Date : 2021-01-01

Eric Weintraub, Aaron D Greenblatt, Joy Chang, Christopher J Welsh, Alexandra P Berthiaume, Shelby R Goodwin, Rachel Arnold, Seth S Himelhoch, Melanie E Bennett, Annabelle M Belcher

This report builds on a previous study that describes the collaboration between an urban academic medical center and a rural drug treatment center, the goal of which is to provide medication-based treatment to individuals with OUD via videoconferencing. We describe results of a retrospective chart review of 472 patients treated in the program between August 2015 and April 2019. We examined several demographic and substance use variables for individuals who consented to telemedicine treatment, retention in treatment over time, and opioid use over time to understand further the impact of prescribing buprenorphine and naltrexone via telemedicine to patients in a rural OUD treatment setting. Our findings support the effectiveness of prescribing medications via telemedicine. The inclusion of more than three times as many patients as in our prior report revealed retention rates and toxicology results that are comparable to face-to-face treatment. These findings have implications for policymakers and clinicians considering implementation of similar programs.

本报告以之前的一项研究为基础，描述了一个城市学术医疗中心与一个农村戒毒治疗中心之间的合作，其目标是通过视频会议为 OUD 患者提供基于药物的治疗。我们描述了对 2015 年 8 月至 2019 年 4 月期间接受该项目治疗的 472 名患者的回顾性病历审查结果。我们研究了同意接受远程医疗治疗的患者的几个人口统计学和药物使用变量、随时间推移的治疗保留率以及随时间推移的阿片类药物使用情况，以进一步了解通过远程医疗向农村 OUD 治疗环境中的患者开具丁丙诺啡和纳曲酮的影响。我们的研究结果支持通过远程医疗开具药物处方的有效性。我们纳入的患者人数是上一份报告的三倍多，结果显示保留率和毒理学结果与面对面治疗相当。这些研究结果对考虑实施类似项目的政策制定者和临床医生具有借鉴意义。

{"title":"Outcomes for patients receiving telemedicine-delivered medication-based treatment for Opioid Use Disorder: A retrospective chart review.","authors":"Eric Weintraub, Aaron D Greenblatt, Joy Chang, Christopher J Welsh, Alexandra P Berthiaume, Shelby R Goodwin, Rachel Arnold, Seth S Himelhoch, Melanie E Bennett, Annabelle M Belcher","doi":"","DOIUrl":"","url":null,"abstract":"This report builds on a previous study that describes the collaboration between an urban academic medical center and a rural drug treatment center, the goal of which is to provide medication-based treatment to individuals with OUD via videoconferencing. We describe results of a retrospective chart review of 472 patients treated in the program between August 2015 and April 2019. We examined several demographic and substance use variables for individuals who consented to telemedicine treatment, retention in treatment over time, and opioid use over time to understand further the impact of prescribing buprenorphine and naltrexone via telemedicine to patients in a rural OUD treatment setting. Our findings support the effectiveness of prescribing medications via telemedicine. The inclusion of more than three times as many patients as in our prior report revealed retention rates and toxicology results that are comparable to face-to-face treatment. These findings have implications for policymakers and clinicians considering implementation of similar programs.","PeriodicalId":45101,"journal":{"name":"Heroin Addiction and Related Clinical Problems","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861202/pdf/nihms-1642372.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25340974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The association between somatic complaints and past-30 day opioid misuse among justice-involved children. 涉及司法的儿童的躯体抱怨与过去30天阿片类药物滥用之间的关系。

IF 0.9 4区医学 Q3 Medicine

Heroin Addiction and Related Clinical Problems

Pub Date : 2020-12-01

Micah E Johnson, Sarah Clerjuste

Background: Individuals in the criminal justice system are especially vulnerable to the adverse effects of opioid misuse. Research on justice-involved children (JIC) is needed to uncover the variables that predict opioid misuse initiation to prevent misuse or reduce harm in this population. Somatic symptoms are symptoms experienced in the body, such as physical sensations, movements or experiences, which can cause severe distress and dysfunction. These include pain, nausea, dizziness, and fainting. In this study, we hypothesize that somatic complaints will be associated with a higher likelihood of opioid misuse among Florida JIC.

Methods: The study examined statewide data on 79,960 JIC in the Florida Department of Juvenile Justice database. Logistic regression was employed to investigate an ordinal measure of somatic complaints at first screen and a binary outcome measure of past-30 day illicit or nonmedical opioid use at final screen while controlling for sociodemographic and mental health factors.

Results: Nearly 28% of JIC had a history of one or more somatic complaints. Compared to those with no history of somatic complaints, JIC with a history of one or two somatic complaints were 1.23 times more likely to misuse opioids in the past 30 days and those with three or four somatic complaints were 1.5 times more likely to meet criteria for past-30 day opioid misuse.

Conclusions: Individuals may consume illicit or non-medical prescription opioids to manage somatic symptoms - indicating that increased access to healthcare may reduce misuse. Risk of opioid overdose sharply increases as justice-involved individuals are released from correctional settings largely due to a reduced tolerance to opioids as a result of incarceration and diminished access to legal medicines that are provided in the justice system. Justice systems must ensure seamless access to quality healthcare services as individuals transition from correctional settings to their communities.

背景:刑事司法系统中的个人特别容易受到阿片类药物滥用的不利影响。需要对涉司法儿童(JIC)进行研究，以揭示预测阿片类药物滥用开始的变量，以防止滥用或减少这一人群的伤害。躯体症状是身体经历的症状，如身体感觉、运动或经历，可导致严重的痛苦和功能障碍。这些症状包括疼痛、恶心、头晕和昏厥。在这项研究中，我们假设在佛罗里达JIC中，躯体抱怨将与更高的阿片类药物滥用可能性相关。方法:该研究检查了佛罗里达州少年司法部门数据库中79,960名JIC的全州数据。在控制社会人口统计学和心理健康因素的情况下，采用Logistic回归调查首次筛查时躯体抱怨的序数测量和最后筛查时过去30天非法或非医疗阿片类药物使用的二元结果测量。结果:近28%的JIC患者有一种或多种躯体疾病病史。与无躯体投诉史的JIC相比，有一到两次躯体投诉史的JIC在过去30天内滥用阿片类药物的可能性是1.23倍，而有三到四次躯体投诉的JIC在过去30天内滥用阿片类药物的可能性是1.5倍。结论:个人可能会服用非法或非医疗处方类阿片来控制躯体症状，这表明增加获得医疗保健的机会可能会减少滥用。随着与司法有关的个人从惩教机构获释，阿片类药物过量的风险急剧增加，这主要是由于监禁导致对阿片类药物的耐受性降低，以及司法系统提供的合法药物的获取机会减少。司法系统必须确保在个人从惩教环境过渡到社区时无缝获得优质医疗保健服务。

{"title":"The association between somatic complaints and past-30 day opioid misuse among justice-involved children.","authors":"Micah E Johnson, Sarah Clerjuste","doi":"","DOIUrl":"","url":null,"abstract":"Background: Individuals in the criminal justice system are especially vulnerable to the adverse effects of opioid misuse. Research on justice-involved children (JIC) is needed to uncover the variables that predict opioid misuse initiation to prevent misuse or reduce harm in this population. Somatic symptoms are symptoms experienced in the body, such as physical sensations, movements or experiences, which can cause severe distress and dysfunction. These include pain, nausea, dizziness, and fainting. In this study, we hypothesize that somatic complaints will be associated with a higher likelihood of opioid misuse among Florida JIC.Methods: The study examined statewide data on 79,960 JIC in the Florida Department of Juvenile Justice database. Logistic regression was employed to investigate an ordinal measure of somatic complaints at first screen and a binary outcome measure of past-30 day illicit or nonmedical opioid use at final screen while controlling for sociodemographic and mental health factors.Results: Nearly 28% of JIC had a history of one or more somatic complaints. Compared to those with no history of somatic complaints, JIC with a history of one or two somatic complaints were 1.23 times more likely to misuse opioids in the past 30 days and those with three or four somatic complaints were 1.5 times more likely to meet criteria for past-30 day opioid misuse.Conclusions: Individuals may consume illicit or non-medical prescription opioids to manage somatic symptoms - indicating that increased access to healthcare may reduce misuse. Risk of opioid overdose sharply increases as justice-involved individuals are released from correctional settings largely due to a reduced tolerance to opioids as a result of incarceration and diminished access to legal medicines that are provided in the justice system. Justice systems must ensure seamless access to quality healthcare services as individuals transition from correctional settings to their communities.","PeriodicalId":45101,"journal":{"name":"Heroin Addiction and Related Clinical Problems","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694337/pdf/nihms-1758370.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39636090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Passive Microwave Radiometry (MWR) for diagnostics of COVID-19 lung complications. 被动微波辐射测量(MWR)用于诊断COVID-19肺部并发症。

IF 0.9 4区医学 Q3 Medicine

Heroin Addiction and Related Clinical Problems

Pub Date : 2020-09-30 DOI: 10.1101/2020.09.29.20202598

B. Osmonov, L. Ovchinnikov, C. Galazis, Berik Emilov, Mustafa Karaibragimov, Meder Seitov, S. Vesnin, Chingiz Mustafin, T. Kasymbekov, I. Goryanin

The World Health Organization (WHO) declared COVID-19 it as a global pandemic. It becomes clear that the virus is spreading mostly deadly due to limited access to diagnostics tests and equipment. Traditional radiography and CT remain the main methods of the initial examination of the chest organs. Now, most of the diagnostics has been focused on PCR, chest X-Ray/CT manifestations of COVID-19. However, there are problems with CT due to infection control issues, the inefficiencies introduced in CT room decontamination, and lack of CT availability in LMIC (Low Middle Income Countries). Passive microwave radiometry (MWR) is a cheap, non-radioactive and portable technology. It has already been used for diagnostics of cancer, and other diseases. We have tested if MWR could be used for early diagnostics of pulmonary COVID-19 complications. This was a randomized controlled trial (195 subjects) to evaluate the effectiveness of diagnostics using MWR in patients with pneumonia caused by COVID-19 while they are in hospitals of Kyrgyzstan, and healthy individuals. We have measured skin (IR) and internal (MWR) temperature by recording passive electromagnetic radiation through the chest wall in the projection of the lungs at 30 symmetrical points on both sides. Pneumonia and lung damage were diagnosed by X-RAY/CT scan and doctor final diagnosis (pn+/pn-). COVID-19 was determined by PCR test (covid+/covid-). The best results were obtained between pn-/covid- and pn+/covid+ groups with sensitivity 92% and specificity 75%. Overall, the study suggests that the use of MWR is a convenient and safe method for screening diagnostics in COVID-19 patients with suspected pneumonia. Since MWR is an inexpensive, it will ease the financial burden for both patients and the countries, especially in LMIC

世界卫生组织(WHO)宣布新冠肺炎为全球大流行。很明显，由于获得诊断测试和设备的机会有限，该病毒的传播大多是致命的。传统的x线摄影和CT仍然是胸部器官初步检查的主要方法。目前，大多数诊断都集中在新冠肺炎的PCR、胸部x线/CT表现上。然而，由于感染控制问题，CT室净化效率低下，以及中低收入国家缺乏CT可用性，CT存在问题。被动微波辐射测量(MWR)是一种廉价、无放射性、便携的技术。它已经被用于癌症和其他疾病的诊断。我们已经测试了MWR是否可用于COVID-19肺部并发症的早期诊断。这是一项随机对照试验(195名受试者)，旨在评估在吉尔吉斯斯坦医院使用MWR对COVID-19引起的肺炎患者和健康个体进行诊断的有效性。我们测量了皮肤(IR)和内部(MWR)温度，通过记录通过胸壁在两侧30个对称点的肺投影的被动电磁辐射。通过x线/CT扫描和医生最终诊断(pn+/pn-)诊断肺炎和肺损伤。采用PCR检测covid- 19 (covid+/covid-)。pn-/covid-组和pn+/covid+组的检测结果最佳，敏感性为92%，特异性为75%。总体而言，本研究表明，使用MWR对COVID-19疑似肺炎患者进行筛查诊断是一种方便、安全的方法。由于MWR价格低廉，它将减轻患者和国家的经济负担，特别是中低收入国家

{"title":"Passive Microwave Radiometry (MWR) for diagnostics of COVID-19 lung complications.","authors":"B. Osmonov, L. Ovchinnikov, C. Galazis, Berik Emilov, Mustafa Karaibragimov, Meder Seitov, S. Vesnin, Chingiz Mustafin, T. Kasymbekov, I. Goryanin","doi":"10.1101/2020.09.29.20202598","DOIUrl":"https://doi.org/10.1101/2020.09.29.20202598","url":null,"abstract":"The World Health Organization (WHO) declared COVID-19 it as a global pandemic. It becomes clear that the virus is spreading mostly deadly due to limited access to diagnostics tests and equipment. Traditional radiography and CT remain the main methods of the initial examination of the chest organs. Now, most of the diagnostics has been focused on PCR, chest X-Ray/CT manifestations of COVID-19. However, there are problems with CT due to infection control issues, the inefficiencies introduced in CT room decontamination, and lack of CT availability in LMIC (Low Middle Income Countries). Passive microwave radiometry (MWR) is a cheap, non-radioactive and portable technology. It has already been used for diagnostics of cancer, and other diseases. We have tested if MWR could be used for early diagnostics of pulmonary COVID-19 complications. This was a randomized controlled trial (195 subjects) to evaluate the effectiveness of diagnostics using MWR in patients with pneumonia caused by COVID-19 while they are in hospitals of Kyrgyzstan, and healthy individuals. We have measured skin (IR) and internal (MWR) temperature by recording passive electromagnetic radiation through the chest wall in the projection of the lungs at 30 symmetrical points on both sides. Pneumonia and lung damage were diagnosed by X-RAY/CT scan and doctor final diagnosis (pn+/pn-). COVID-19 was determined by PCR test (covid+/covid-). The best results were obtained between pn-/covid- and pn+/covid+ groups with sensitivity 92% and specificity 75%. Overall, the study suggests that the use of MWR is a convenient and safe method for screening diagnostics in COVID-19 patients with suspected pneumonia. Since MWR is an inexpensive, it will ease the financial burden for both patients and the countries, especially in LMIC","PeriodicalId":45101,"journal":{"name":"Heroin Addiction and Related Clinical Problems","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2020-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85784980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

首页上一页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Heroin Addiction and Related Clinical Problems

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀